Study of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular Degeneration
Condition(s):Neovascular Age-Related Macular DegenerationLast Updated:July 10, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Neovascular Age-Related Macular DegenerationLast Updated:July 10, 2023Completed
Condition(s):Neovascular Age-related Macular DegenerationLast Updated:June 29, 2023Completed
Condition(s):Neovascular Age-related Macular Degeneration (nAMD)Last Updated:February 9, 2024Completed
Condition(s):Neovascular Age-Related Macular DegenerationLast Updated:January 10, 2024Recruiting
Condition(s):Neovascular Age-related Macular DegenerationLast Updated:March 7, 2024Active, not recruiting
Condition(s):Neovascular Age-Related Macular DegenerationLast Updated:January 9, 2024Recruiting
Condition(s):Neovascular Age-related Macular DegenerationLast Updated:March 1, 2018Unknown status
Condition(s):Diabetic Macular Edema; Neovascular Age-related Macular DegenerationLast Updated:March 10, 2022Completed
Condition(s):Neovascular Age-related Macular Degeneration (nAMD)Last Updated:March 6, 2024Recruiting
Condition(s):Neovascular Age-related Macular DegenerationLast Updated:November 16, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.